2019
DOI: 10.12680/balneo.2019.258
|View full text |Cite
|
Sign up to set email alerts
|

Complementary therapeutic approaches in asthma

Abstract: Asthma is defined by The Initiative for Asthma (GINA 2018) as a heterogeneous disease, which include chronic airway inflammation and a history of respiratory symptoms. In the last decades asthma had a rise in prevalence, becoming one of the most frequent diagnosed diseases in the world. The main goals of asthma management are to achieve good symptom control, minimize the risks of exacerbations, decrease rescue medication intake, improve the quality of life by decreasing respiratory system inflammation and amel… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 55 publications
0
8
0
Order By: Relevance
“…Most of the studies dealing with ROS toxicity relied on associations; however, as in the Canadian oxygen trial, no causal link can be provided [ 40 ]. Due to the lack of data on preterm infants, we cannot provide data on complementary approaches that are available, e.g., for asthma patients [ 104 ]. Lastly, for most ROS therapies, no dose-escalation studies are available that might have concealed their efficacy.…”
Section: Unmet Needs and Future Perspectivesmentioning
confidence: 99%
“…Most of the studies dealing with ROS toxicity relied on associations; however, as in the Canadian oxygen trial, no causal link can be provided [ 40 ]. Due to the lack of data on preterm infants, we cannot provide data on complementary approaches that are available, e.g., for asthma patients [ 104 ]. Lastly, for most ROS therapies, no dose-escalation studies are available that might have concealed their efficacy.…”
Section: Unmet Needs and Future Perspectivesmentioning
confidence: 99%
“…Asthma is a heterogeneous condition that is associated with IPF, influencing the prognosis of these patients and remaining poorly controlled despite optimum management. The additional interventions in asthma and IPF management, such as physical training, smoking cessation, environmental control practices, inspiratory muscle training, breathing techniques, speleotherapy and halotherapy have been proven to improve muscle strength, symptomatology, exercise capacity and quality of life (15,51).…”
Section: Asthmamentioning
confidence: 99%
“…Modification of the intestinal microbiome favors respiratory infections [40], with all the implications described above, practically proving that in patients with IPF, they are very difficult to control. In this context, an ideal therapeutic agent should combine the antimicrobial, antiviral, and antifibrotic effects [41,42], although it remains to be discussed whether alternative therapies would have antiviral, antimicrobial, anti-inflammatory and antifibrotic effects [43,44] Herbal remedies such as Black Elder (Sambucus nigra L.) have been identified so far which associates antiviral (herpes simplex virus type 1, influenza virus) and antimicrobial (Streptococcus pneumoniae, Haemophilus influenza, Streptococcus pyogenes, group C and G Streptococci, Branhamella caterrhalis, and Haemophilus influenza) [45] effects, with demonstrated myocardial antifibrotic effects [46] and renal tissue [47].…”
Section: Pulmonary Microbiome and Idiopathic Pulmonary Fibrosismentioning
confidence: 99%